From: Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients
Par. | Test 1 | Test 2 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | 1 year time-point | 3 year time-point |  | 1 year time-point | 3 year time-point |  | ||||||||
 | Med | 25 th | 75 th | Med | 25 th | 75 th | P | Med | 25 th | 75 th | Med | 25 th | 75 th | P |
BD | 4.56 | 4.20 | 4.77 | 4.14 | 3.71 | 4.59 | <0.01 | 4.56 | 4.00 | 4.81 | 4.03 | 3.93 | 4.24 | <0.01 |
MA | 4.37 | 3.91 | 4.60 | 4.06 | 3.52 | 4.38 | <0.01 | 4.22 | 3.67 | 4.73 | 3.95 | 3.70 | 4.06 | <0.01 |
RA | 0.16 | 0.01 | 0.39 | 0.06 | 0.01 | 0.25 | 0.06 | 0.16 | 0.06 | 0.29 | 0.16 | 0.05 | 0.28 | 0.26 |
PC | 0.96 | 0.92 | 1.00 | 0.99 | 0.94 | 1.00 | 0.11 | 0.97 | 0.93 | 0.99 | 0.96 | 0.93 | 0.99 | 0.42 |
-RT | 0.74 | 0.28 | 1.00 | 0.80 | 0.24 | 1.04 | 0.77 | 0.94 | 0.68 | 1.22 | 1.00 | 0.48 | 1.24 | 0.77 |
CV | 0.26 | 0.02 | 0.42 | 0.13 | 0.04 | 0.30 | 0.30 | 0.14 | 0.07 | 0.33 | 0.18 | 0.05 | 0.31 | 0.48 |